Skip to main content
See every side of every news story
Published • loading... • Updated

Exclusive-US FDA shelves commissioner’s voucher program for speedy drug reviews, sources say

The pilot aimed to cut reviews to one to two months, but no new vouchers have been issued since Marty Makary left the agency.

Summary by WTVB
By Patrick Wingrove and Yasmeen Abutaleb NEW YORK, Nov 12 (Reuters) – The US Food and Drug Administration has shelved the fast-track drug review initiative launched during the Trump administration by former Commissioner Marty Makary, according to six sources familiar with the matter and internal documents. Launched in June 2025, the Commissioner’s National Priority Voucher program aimed to slash drug review timelines to just one to two months fo…

7 Articles

Think freely.Subscribe and get full access to Ground NewsSubscriptions start at $9.99/yearSubscribe

Bias Distribution

  • 40% of the sources lean Left, 40% of the sources are Center
40% Center

Factuality Info Icon

To view factuality data please Upgrade to Premium

Ownership

Info Icon

To view ownership data please Upgrade to Vantage

WTVB broke the news on Thursday, November 12, 2026.
Too Big Arrow Icon
Sources are mostly out of (0)

Similar News Topics

News
Feed Dots Icon
For You
Search Icon
Search
Blindspot LogoBlindspotLocal